Literature DB >> 22540540

Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage™.

Taline V Khroyan1, Jingxi Zhang, Liya Yang, Bende Zou, James Xie, Conrado Pascual, Adam Malik, Julian Xie, Nurulain T Zaveri, Jacqueline Vazquez, Willma Polgar, Lawrence Toll, Jidong Fang, Xinmin Xie.   

Abstract

1. To facilitate investigation of diverse rodent behaviours in rodents' home cages, we have developed an integrated modular platform, the SmartCage(™) system (AfaSci, Inc. Burlingame, CA, USA), which enables automated neurobehavioural phenotypic analysis and in vivo drug screening in a relatively higher-throughput and more objective manner. 2, The individual platform consists of an infrared array, a vibration floor sensor and a variety of modular devices. One computer can simultaneously operate up to 16 platforms via USB cables. 3. The SmartCage(™) detects drug-induced increases and decreases in activity levels, as well as changes in movement patterns. Wake and sleep states of mice can be detected using the vibration floor sensor. The arousal state classification achieved up to 98% accuracy compared with results obtained by electroencephalography and electromyography. More complex behaviours, including motor coordination, anxiety-related behaviours and social approach behaviour, can be assessed using appropriate modular devices and the results obtained are comparable with results obtained using conventional methods. 4. In conclusion, the SmartCage(™) system provides an automated and accurate tool to quantify various rodent behaviours in a 'stress-free' environment. This system, combined with the validated testing protocols, offers powerful a tool kit for transgenic phenotyping and in vivo drug screening.
© 2012 The Authors. Clinical and Experimental Pharmacology and Physiology © 2012 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22540540      PMCID: PMC5567678          DOI: 10.1111/j.1440-1681.2012.05719.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  28 in total

1.  Neurobehavioral changes in mice chronically exposed to methylmercury during fetal and early postnatal development.

Authors:  S Goulet; F Y Doré; M-E Mirault
Journal:  Neurotoxicol Teratol       Date:  2003 May-Jun       Impact factor: 3.763

2.  Pharmacological validation of a novel home cage activity counter in mice.

Authors:  K Ganea; C Liebl; V Sterlemann; M B Müller; M V Schmidt
Journal:  J Neurosci Methods       Date:  2007-01-20       Impact factor: 2.390

3.  Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration.

Authors:  Leann P Quinn; Tania O Stean; Helen Chapman; Matthew Brown; Martin Vidgeon-Hart; Neil Upton; Andrew Billinton; David J Virley
Journal:  J Neurosci Methods       Date:  2006-04-19       Impact factor: 2.390

Review 4.  Optogenetic investigation of neural circuits in vivo.

Authors:  Matthew E Carter; Luis de Lecea
Journal:  Trends Mol Med       Date:  2011-02-23       Impact factor: 11.951

5.  Designing mouse behavioral tasks relevant to autistic-like behaviors.

Authors:  Jacqueline N Crawley
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

Review 6.  Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies.

Authors:  J N Crawley; J K Belknap; A Collins; J C Crabbe; W Frankel; N Henderson; R J Hitzemann; S C Maxson; L L Miner; A J Silva; J M Wehner; A Wynshaw-Boris; R Paylor
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

7.  Automated apparatus for quantitation of social approach behaviors in mice.

Authors:  J J Nadler; S S Moy; G Dold; D Trang; N Simmons; A Perez; N B Young; R P Barbaro; J Piven; T R Magnuson; J N Crawley
Journal:  Genes Brain Behav       Date:  2004-10       Impact factor: 3.449

8.  A robust automated system elucidates mouse home cage behavioral structure.

Authors:  Evan H Goulding; A Katrin Schenk; Punita Juneja; Adrienne W MacKay; Jennifer M Wade; Laurence H Tecott
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-23       Impact factor: 11.205

9.  Sleep is increased by weight gain and decreased by weight loss in mice.

Authors:  Zhiwei Guan; Alexandros N Vgontzas; Edward O Bixler; Jidong Fang
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

10.  A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor.

Authors:  Nurulain T Zaveri; Faming Jiang; Cris M Olsen; Jeffrey R Deschamps; Damon Parrish; Willma Polgar; Lawrence Toll
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

View more
  22 in total

1.  ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice.

Authors:  Kristian Kaufmann; Ian Romaine; Emily Days; Conrado Pascual; Adam Malik; Liya Yang; Bende Zou; Yu Du; Greg Sliwoski; Ryan D Morrison; Jerod Denton; Colleen M Niswender; J Scott Daniels; Gary A Sulikowski; Xinmin Simon Xie; Craig W Lindsley; C David Weaver
Journal:  ACS Chem Neurosci       Date:  2013-06-13       Impact factor: 4.418

2.  Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep.

Authors:  Bende Zou; William S Cao; Zhiwei Guan; Kui Xiao; Conrado Pascual; Julian Xie; Jingxi Zhang; James Xie; Frank Kayser; Craig W Lindsley; C David Weaver; Jidong Fang; Xinmin Simon Xie
Journal:  Sleep       Date:  2019-03-01       Impact factor: 5.849

3.  Analgesic Microneedle Patch for Neuropathic Pain Therapy.

Authors:  Xi Xie; Conrado Pascual; Christopher Lieu; Seajin Oh; Ji Wang; Bende Zou; Julian Xie; Zhaohui Li; James Xie; David C Yeomans; Mei X Wu; Xinmin Simon Xie
Journal:  ACS Nano       Date:  2016-12-27       Impact factor: 15.881

4.  BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.

Authors:  T V Khroyan; J Wu; W E Polgar; G Cami-Kobeci; N Fotaki; S M Husbands; L Toll
Journal:  Br J Pharmacol       Date:  2014-11-05       Impact factor: 8.739

5.  AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.

Authors:  Andrea Cippitelli; Jinhua Wu; Kelly A Gaiolini; Daniela Mercatelli; Jennifer Schoch; Michelle Gorman; Alejandra Ramirez; Roberto Ciccocioppo; Taline V Khroyan; Dennis Yasuda; Nurulain T Zaveri; Conrado Pascual; Xinmin Simon Xie; Lawrence Toll
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

6.  Noninvasive three-state sleep-wake staging in mice using electric field sensors.

Authors:  H Kloefkorn; L M Aiani; A Lakhani; S Nagesh; A Moss; W Goolsby; J M Rehg; N P Pedersen; S Hochman
Journal:  J Neurosci Methods       Date:  2020-06-30       Impact factor: 2.390

7.  Mitigation of murine focal cerebral ischemia by the hypocretin/orexin system is associated with reduced inflammation.

Authors:  Xiaoxing Xiong; Robin E White; Lijun Xu; Liya Yang; Xiaoyun Sun; Bende Zou; Conrado Pascual; Takeshi Sakurai; Rona G Giffard; Xinmin Simon Xie
Journal:  Stroke       Date:  2013-01-24       Impact factor: 7.914

8.  Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity.

Authors:  Jacqueline Vazquez-DeRose; Gregory Stauber; Taline V Khroyan; Xinmin Simon Xie; Nurulain T Zaveri; Lawrence Toll
Journal:  Eur J Pharmacol       Date:  2012-12-05       Impact factor: 4.432

9.  A Thermal Place Preference Test for Discovery of Neuropathic Pain Drugs.

Authors:  Joel Caporoso; Mark Moses; Kerryann Koper; Tommy S Tillman; Lingling Jiang; Nicole Brandon; Qiang Chen; Pei Tang; Yan Xu
Journal:  ACS Chem Neurosci       Date:  2020-03-24       Impact factor: 4.418

10.  CX3CR1 ablation ameliorates motor and respiratory dysfunctions and improves survival of a Rett syndrome mouse model.

Authors:  Makoto Horiuchi; Lucas Smith; Izumi Maezawa; Lee-Way Jin
Journal:  Brain Behav Immun       Date:  2016-02-13       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.